Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -14.80%164.6M | -19.14%177.9M | -11.74%196.2M | -8.78%798.6M | -15.88%163.1M | 2.33%193.2M | -11.82%220M | -8.63%222.3M | -19.35%875.5M | -27.68%193.9M |
| Operating revenue | -14.80%164.6M | -19.14%177.9M | -11.74%196.2M | -8.78%798.6M | -15.88%163.1M | 2.33%193.2M | -11.82%220M | -8.63%222.3M | -19.35%875.5M | -27.68%193.9M |
| Cost of revenue | 2.01%147.1M | -14.59%149.9M | -20.56%148.4M | -18.53%633.6M | -21.30%127.1M | -21.97%144.2M | -22.35%175.5M | -7.62%186.8M | -10.28%777.7M | -31.28%161.5M |
| Gross profit | -64.29%17.5M | -37.08%28M | 34.65%47.8M | 68.71%165M | 11.11%36M | 1,125.00%49M | 89.36%44.5M | -13.63%35.5M | -55.30%97.8M | -2.11%32.4M |
| Operating expense | -29.18%33.5M | -33.53%33.3M | -27.73%37M | -19.88%180.5M | -32.84%31.9M | -11.26%47.3M | -17.60%50.1M | -19.62%51.2M | -15.71%225.3M | -31.95%47.5M |
| Selling and administrative expenses | -18.21%24.7M | -26.87%24.5M | -22.74%26.5M | -13.26%121.7M | -24.28%23.7M | -4.73%30.2M | -12.30%33.5M | -12.28%34.3M | -17.23%140.3M | -27.88%31.3M |
| -Selling and marketing expense | -18.21%24.7M | -26.87%24.5M | -22.74%26.5M | -13.26%121.7M | -24.28%23.7M | -4.73%30.2M | -12.30%33.5M | -12.28%34.3M | -17.23%140.3M | -27.88%31.3M |
| -General and administrative expense | ---- | ---- | ---- | -5.80%26M | -24.62%4.9M | 1.54%6.6M | 6.67%6.4M | -18.60%7M | -4.83%27.6M | -24.42%6.5M |
| Depreciation amortization depletion | -48.54%8.8M | -46.99%8.8M | -37.87%10.5M | -30.82%58.8M | -49.38%8.2M | -20.83%17.1M | -26.55%16.6M | -31.30%16.9M | -13.09%85M | -38.64%16.2M |
| -Depreciation and amortization | -48.54%8.8M | -46.99%8.8M | -37.87%10.5M | -30.82%58.8M | -49.38%8.2M | -20.83%17.1M | -26.55%16.6M | -31.30%16.9M | -13.09%85M | -38.64%16.2M |
| Operating profit | -1,041.18%-16M | 5.36%-5.3M | 168.79%10.8M | 87.84%-15.5M | 127.15%4.1M | 103.45%1.7M | 84.99%-5.6M | 30.53%-15.7M | -162.89%-127.5M | 58.86%-15.1M |
| Net non-operating interest income (expenses) | 22.22%-2.8M | 29.73%-2.6M | 33.33%-2.8M | -8.33%-14.3M | 22.22%-2.8M | -9.09%-3.6M | 2.63%-3.7M | -68.00%-4.2M | -80.82%-13.2M | -38.46%-3.6M |
| Non-operating interest income | ---- | ---- | ---- | 80.00%900K | ---- | ---- | ---- | ---- | 66.67%500K | ---- |
| Non-operating interest expense | -22.22%2.8M | -29.73%2.6M | -33.33%2.8M | 15.87%14.6M | 3.33%3.1M | 9.09%3.6M | -2.63%3.7M | 68.00%4.2M | 80.00%12.6M | 30.43%3M |
| Total other finance cost | ---- | ---- | ---- | -45.45%600K | ---- | ---- | ---- | ---- | 83.33%1.1M | ---- |
| Other net income (expenses) | 100.80%1.7M | -257.14%-1.1M | -98.18%300K | -2,441.46%-192M | 933.33%2.5M | -6,715.63%-211.7M | -69.57%700K | 8,350.00%16.5M | 115.62%8.2M | 99.47%-300K |
| Special income (charges) | --0 | ---- | ---- | ---211M | --0 | ---211M | -883.33%-5.9M | --0 | --0 | --0 |
| -Less:Restructuring and mergern&acquisition | ---- | ---- | ---- | ---- | ---- | ---- | 883.33%5.9M | --0 | ---- | ---- |
| -Less:Impairment of capital assets | ---- | ---- | ---- | --206.9M | ---- | ---- | ---- | ---- | ---- | ---- |
| -Less:Write off | --0 | ---- | ---- | --4.1M | ---206.9M | --211M | ---- | ---- | --0 | --0 |
| Other non-operating income (expenses) | 342.86%1.7M | -257.14%-1.1M | -98.18%300K | 131.71%19M | 933.33%2.5M | -121.88%-700K | -75.86%700K | 587.50%16.5M | 64.00%8.2M | 83.33%-300K |
| Income before tax | 91.99%-17.1M | -4.65%-9M | 344.12%8.3M | -67.40%-221.8M | 120.00%3.8M | -332.39%-213.6M | 77.84%-8.6M | 86.56%-3.4M | -22.35%-132.5M | 80.10%-19M |
| Income tax | 91.83%-4.7M | 0.00%-2.3M | 330.00%2.3M | -64.56%-59.9M | 115.52%900K | -319.71%-57.5M | 77.88%-2.3M | 84.62%-1M | -24.66%-36.4M | 77.43%-5.8M |
| Earnings from equity interest net of tax | ||||||||||
| Net income | 92.06%-12.4M | -6.35%-6.7M | 350.00%6M | -68.47%-161.9M | 121.97%2.9M | -337.25%-156.1M | 77.82%-6.3M | 87.23%-2.4M | -21.49%-96.1M | 81.09%-13.2M |
| Net income continuous operations | 92.06%-12.4M | -6.35%-6.7M | 350.00%6M | -68.47%-161.9M | 121.97%2.9M | -337.25%-156.1M | 77.82%-6.3M | 87.23%-2.4M | -21.49%-96.1M | 81.09%-13.2M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 92.06%-12.4M | -6.35%-6.7M | 350.00%6M | -68.47%-161.9M | 121.97%2.9M | -337.25%-156.1M | 77.82%-6.3M | 87.23%-2.4M | -21.49%-96.1M | 81.09%-13.2M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 92.06%-12.4M | -6.35%-6.7M | 350.00%6M | -68.47%-161.9M | 121.97%2.9M | -337.25%-156.1M | 77.82%-6.3M | 87.23%-2.4M | -21.49%-96.1M | 81.09%-13.2M |
| Diluted earnings per share | 92.05%-0.19 | 0.00%-0.1 | 325.00%0.09 | -69.39%-2.49 | 120.00%0.04 | -334.55%-2.39 | 77.27%-0.1 | 86.21%-0.04 | -21.49%-1.47 | 81.31%-0.2 |
| Basic earnings per share | 92.05%-0.19 | 0.00%-0.1 | 325.00%0.09 | -69.39%-2.49 | 120.00%0.04 | -334.55%-2.39 | 77.27%-0.1 | 86.21%-0.04 | -21.49%-1.47 | 81.31%-0.2 |
| Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.